Ironwood Pharmaceuticals Stock
Ironwood Pharmaceuticals Stock
The Ironwood Pharmaceuticals stock is trending slightly upwards today, with an increase of €0.050 (0.690%) compared to yesterday's price.
With 7 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 7.25 € the target price of 19 € shows a potential of 162.07% for Ironwood Pharmaceuticals which would more than double the current price.
Pros and Cons of Ironwood Pharmaceuticals in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ironwood Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals | 0.690% | -2.685% | -8.228% | -22.872% | -28.922% | -21.622% | - |
| Novocure Ltd | -2.010% | 1.864% | -20.671% | -80.817% | -19.615% | -93.244% | - |
| Sage Therapeutics Inc. | -1.020% | 7.851% | -25.000% | -69.792% | -34.750% | -79.867% | - |
| Iovance Biotherapeutics Inc. | 3.560% | 1.006% | -19.239% | 115.878% | 41.393% | -57.814% | - |
Comments
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target raised by analysts at Piper Sandler from $20.00 to $21.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat